Login

Targovax presentation at Redeye Fight Cancer - Erik Digman Wiklund, CEO, Targovax 00:00:00

Share On Facebook Share On Twitter

Targovax presentation at Redeye Fight Cancer

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The Surge in Iraq: Strategy, Challenges, and Successes|Jack Keane
00:10:00
Navigating Waste Management: Insights from Waste Management, Inc. CEO
00:10:00
Middle Market Lending Trends and Industry Focus
00:10:00
Cobalt Blue: Advancing Australia's Largest Primary Cobalt Source
00:10:00
Asante Gold's Transformation: From Acquisition to Gold Production at Bibiani Mine
00:10:00
Revolutionizing Mining: Real-Time Data and Ventilation On-Demand Enhance Safety and Efficiency
00:10:00
Evolution of Investment Excellence: A CEO's Vision for Wellington Management | Jean Hynes , CEO , Wellington Management.
00:10:00
Concentration vs. Diversification: Key Insights on Investing Strategies
00:10:00
Apollo's growth strategy, his views on alternative investments, and why he believes alts could soon make up 50 percent of individuals' portfolios|Marc Rowan, CEO and Co-Founder of Apollo Global Management
00:10:00
Exploring the Potential of CanAlaska Uranium Ltd. in Canada's Athabasca Basin
00:10:00
Southern Palladium's Penguin Armor Project Set to List on ASX and JSE, Highlights Shallow Advanced Exploration Potential
00:10:00
Jake's Take: Election Year Planning | Castlepoint Wealth Advisors

© 2026 Nehu